Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc DGNOF


Primary Symbol: V.ADK

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants

GlobeNewswire November 6, 2018

DIAGNOS Announces Closing of Private Placement of Common Stocks and Stock Warrants

GlobeNewswire November 1, 2018

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants & Shares for Debt

GlobeNewswire October 24, 2018

DIAGNOS to Provide Retinal Image Analysis using its AI Technology to 20/20NOW, the Leading Ocular Telehealth Provider in the United States

GlobeNewswire September 18, 2018

DIAGNOS Announces Closing of Private Placement of Common Stocks and Stock Warrants

GlobeNewswire September 11, 2018

DIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease

GlobeNewswire September 5, 2018

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants

GlobeNewswire August 24, 2018

DIAGNOS Provides Update on Business Operations

GlobeNewswire July 31, 2018

DIAGNOS Installs its First Retina Screening Clinic based on Artificial Intelligence in Panama

GlobeNewswire July 10, 2018

DIAGNOS Closes Second and Final Tranche of Private Placement

GlobeNewswire July 5, 2018

DIAGNOS Broadens its Collaboration with the Government of Mexico

GlobeNewswire July 4, 2018

DIAGNOS Provides Financing Updates

GlobeNewswire June 29, 2018

DIAGNOS Hires Investor Relation Firm Momentum Public Relations and Provides Financing Update

GlobeNewswire June 14, 2018

DIAGNOS Announces the Availability of its New CARA High Blood Pressure Risk Assessment Based on its FLAIRE Artificial Intelligence Platform

GlobeNewswire June 12, 2018

REMINDER: DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support of the Québec government

GlobeNewswire June 6, 2018

DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support of the Québec government

GlobeNewswire June 5, 2018

DIAGNOS Announces Private Placement and Stock Options Grant

GlobeNewswire May 28, 2018

DIAGNOS Sells 10,500,000 Common Shares of Albert Mining Inc.

GlobeNewswire April 6, 2018

DIAGNOS Welcomes Dr. Reid Maclellan to the Board of Directors

GlobeNewswire April 4, 2018

DIAGNOS Announces the Opening of a Screening Clinic at Chaparral’s Health Management Wellness Center for Medicare Beneficiaries

GlobeNewswire March 14, 2018